» Articles » PMID: 32291306

Intercellular Transmission of a Synthetic Bacterial Cytotoxic Prion-Like Protein in Mammalian Cells

Overview
Journal mBio
Specialty Microbiology
Date 2020 Apr 16
PMID 32291306
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

RepA is a bacterial protein that builds intracellular amyloid oligomers acting as inhibitory complexes of plasmid DNA replication. When carrying a mutation enhancing its amyloidogenesis (A31V), the N-terminal domain (WH1) generates cytosolic amyloid particles that are inheritable within a bacterial lineage. Such amyloids trigger in bacteria a lethal cascade reminiscent of mitochondrial impairment in human cells affected by neurodegeneration. To fulfill all the criteria to qualify as a prion-like protein, horizontal (intercellular) transmissibility remains to be demonstrated for RepA-WH1. Since this is experimentally intractable in bacteria, here we transiently expressed in a murine neuroblastoma cell line the soluble, barely cytotoxic RepA-WH1 wild type [RepA-WH1(WT)] and assayed its response to exposure to -assembled RepA-WH1(A31V) amyloid fibers. In parallel, murine cells releasing RepA-WH1(A31V) aggregates were cocultured with human neuroblastoma cells expressing RepA-WH1(WT). Both the assembled fibers and donor-derived RepA-WH1(A31V) aggregates induced, in the cytosol of recipient cells, the formation of cytotoxic amyloid particles. Mass spectrometry analyses of the proteomes of both types of injured cells pointed to alterations in mitochondria, protein quality triage, signaling, and intracellular traffic. Thus, a synthetic prion-like protein can be propagated to, and become cytotoxic to, cells of organisms placed at such distant branches of the tree of life as bacteria and mammalia, suggesting that mechanisms of protein aggregate spreading and toxicity follow default pathways. Proteotoxic amyloid seeds can be transmitted between mammalian cells, arguing that the intercellular exchange of prion-like protein aggregates can be a common phenomenon. RepA-WH1 is derived from a bacterial intracellular functional amyloid protein, engineered to become cytotoxic in Here, we have studied if such bacterial aggregates can also be transmitted to, and become cytotoxic to, mammalian cells. We demonstrate that RepA-WH1 is capable of entering naive cells, thereby inducing the cytotoxic aggregation of a soluble RepA-WH1 variant expressed in the cytosol, following the same trend that had been described in bacteria. These findings highlight the universality of one of the central principles underlying prion biology: No matter the biological origin of a given prion-like protein, it can be transmitted to a phylogenetically unrelated recipient cell, provided that the latter expresses a soluble protein onto which the incoming protein can readily template its amyloid conformation.

Citing Articles

The emergence of bacterial prions.

Giraldo R PLoS Pathog. 2024; 20(6):e1012253.

PMID: 38870093 PMC: 11175392. DOI: 10.1371/journal.ppat.1012253.


A Potential Role of the Spike Protein in Neurodegenerative Diseases: A Narrative Review.

Seneff S, Kyriakopoulos A, Nigh G, McCullough P Cureus. 2023; 15(2):e34872.

PMID: 36788995 PMC: 9922164. DOI: 10.7759/cureus.34872.


Microbiome Impact on Amyloidogenesis.

Seira Curto J, Surroca Lopez A, Casals Sanchez M, Tic I, Fernandez Gallegos M, Sanchez de Groot N Front Mol Biosci. 2022; 9:926702.

PMID: 35782871 PMC: 9245625. DOI: 10.3389/fmolb.2022.926702.


Analysis of chronic inflammatory lesions of the colon for BMMF Rep antigen expression and CD68 macrophage interactions.

Bund T, Nikitina E, Chakraborty D, Ernst C, Gunst K, Boneva B Proc Natl Acad Sci U S A. 2021; 118(12).

PMID: 33723077 PMC: 8000208. DOI: 10.1073/pnas.2025830118.


SynBio and the Boundaries between Functional and Pathogenic RepA-WH1 Bacterial Amyloids.

Giraldo R mSystems. 2020; 5(3).

PMID: 32606029 PMC: 7329326. DOI: 10.1128/mSystems.00553-20.

References
1.
Clavaguera F, Bolmont T, Crowther R, Abramowski D, Frank S, Probst A . Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol. 2009; 11(7):909-13. PMC: 2726961. DOI: 10.1038/ncb1901. View

2.
Gasset-Rosa F, Coquel A, Moreno-Del Alamo M, Chen P, Song X, Serrano A . Direct assessment in bacteria of prionoid propagation and phenotype selection by Hsp70 chaperone. Mol Microbiol. 2014; 91(6):1070-87. DOI: 10.1111/mmi.12518. View

3.
Prusiner S, Woerman A, Mordes D, Watts J, Rampersaud R, Berry D . Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A. 2015; 112(38):E5308-17. PMC: 4586853. DOI: 10.1073/pnas.1514475112. View

4.
Haelterman N, Yoon W, Sandoval H, Jaiswal M, Shulman J, Bellen H . A mitocentric view of Parkinson's disease. Annu Rev Neurosci. 2014; 37:137-59. PMC: 4659514. DOI: 10.1146/annurev-neuro-071013-014317. View

5.
Kordower J, Chu Y, Hauser R, Freeman T, Olanow C . Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med. 2008; 14(5):504-6. DOI: 10.1038/nm1747. View